December 14, 2017 05:14 PM ESTUpdated 05:28 PM
Financing
Startups

Jnana launch­es with $50M to spot­light an un­ex­plored pro­tein ter­ri­to­ry

Brittany Meiling

Boston start­up Jnana Ther­a­peu­tics is launch­ing with a $50 mil­lion Se­ries A round to de­vel­op a drug dis­cov­ery plat­form it hopes will push the en­ve­lope …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times